Geode Capital Management, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.63 - $21.74 $456,581 - $563,022	25,898 Added 3.7%	725,511 $14.3 Million
Q4 2023 Feb 13, 2024	BUY	$14.37 - $19.07 $575,432 - $763,639	40,044 Added 6.07%	699,613 $12.3 Million
Q3 2023 Nov 13, 2023	BUY	$13.62 - $20.2 $639,009 - $947,723	46,917 Added 7.66%	659,569 $11.5 Million
Q2 2023 Aug 11, 2023	BUY	$10.44 - $16.48 $452,292 - $713,963	43,323 Added 7.61%	612,652 $8.63 Million
Q1 2023 May 15, 2023	BUY	$10.7 - $15.79 $267,414 - $394,623	24,992 Added 4.59%	569,329 $6.13 Million
Q4 2022 Feb 13, 2023	BUY	$11.42 - $17.05 $238,266 - $355,731	20,864 Added 3.99%	544,337 $8.15 Million
Q3 2022 Nov 14, 2022	SELL	$9.76 - $13.41 $78,040 - $107,226	-7,996 Reduced 1.5%	523,473 $6.72 Million
Q2 2022 Aug 12, 2022	BUY	$7.6 - $11.41 $92,530 - $138,916	12,175 Added 2.34%	531,469 $5.15 Million
Q1 2022 May 13, 2022	SELL	$9.3 - $12.37 $129,483 - $172,227	-13,923 Reduced 2.61%	519,294 $5.16 Million
Q4 2021 Feb 11, 2022	BUY	$10.39 - $15.15 $590,380 - $860,853	56,822 Added 11.93%	533,217 $6.28 Million
Q3 2021 Nov 12, 2021	BUY	$11.39 - $16.23 $199,735 - $284,609	17,536 Added 3.82%	476,395 $5.43 Million
Q2 2021 Aug 13, 2021	BUY	$13.22 - $19.09 $475,259 - $686,285	35,950 Added 8.5%	458,859 $6.39 Million
Q1 2021 May 12, 2021	BUY	$16.68 - $23.97 $741,042 - $1.06 Million	44,427 Added 11.74%	422,909 $7.83 Million
Q4 2020 Feb 12, 2021	BUY	$14.8 - $21.15 $467,576 - $668,191	31,593 Added 9.11%	378,482 $6.69 Million
Q3 2020 Nov 13, 2020	BUY	$15.21 - $25.53 $1.7 Million - $2.86 Million	111,903 Added 47.62%	346,889 $5.31 Million
Q2 2020 Aug 13, 2020	BUY	$15.08 - $26.0 $465,021 - $801,762	30,837 Added 15.11%	234,986 $5.99 Million
Q1 2020 May 14, 2020	BUY	$11.0 - $19.76 $149,941 - $269,348	13,631 Added 7.15%	204,149 $3.16 Million
Q4 2019 Feb 13, 2020	BUY	$5.24 - $12.96 $128,993 - $319,036	24,617 Added 14.84%	190,518 $2.11 Million
Q3 2019 Nov 12, 2019	BUY	$8.15 - $15.88 $30,904 - $60,216	3,792 Added 2.34%	165,901 $1.41 Million
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.39 $158,571 - $244,945	12,013 Added 8.0%	162,109 $2.19 Million
Q1 2019 May 14, 2019	BUY	$15.93 - $26.59 $849,785 - $1.42 Million	53,345 Added 55.14%	150,096 $2.71 Million
Q4 2018 Feb 13, 2019	SELL	$16.25 - $28.09 $6,045 - $10,449	-372 Reduced 0.38%	96,751 $2.72 Million
Q3 2018 Nov 13, 2018	BUY	$13.23 - $30.93 $1.28 Million - $3 Million	97,123 New	97,123 $2.48 Million

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$33.1 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.42 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

97.5K
Shares

$2.13 Million
0.11% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$860,794
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$654,000
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account